`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`MEDTRONIC, INC., AND MEDTRONIC VASCULAR, INC.,
`Petitioner,
`
`v.
`
`TELEFLEX INNOVATIONS S.À.R.L.,
`Patent Owner.
`
`
`Case IPR2020-00127
`Patent 8,048,032
`
`
`
`PETITIONERS’ OBJECTIONS UNDER 37 C.F.R. § 42.64 TO PATENT
`OWNER’S POST-INSTITUTION EVIDENCE
`
`
`
`IPR2020-00127
`Patent 8,048,032
`
`
`Pursuant to 37 C.F.R. § 42.64(b)(1), Petitioners Medtronic, Inc. and
`
`Medtronic Vascular, Inc. (“Medtronic”) submit the following objections to certain
`
`post-institution evidence filed by Patent Owner Teleflex Innovations S.À.R.L
`
`(“Teleflex”) on September 24, 2020.
`
`Medtronic renews and incorporates its objections to Patent Owner’s pre-
`
`institution evidence.
`
`I.
`
`Exhibit 2124: Declaration of Peter Keith
`
`Medtronic has yet to cross-examine Mr. Keith, but it intends to do so before
`
`DUE DATE 2. Medtronic therefore reserves the right to move to exclude Exhibit
`
`2124 and/or any testimony therein based on FRE 401/402 (relevance), FRE 403
`
`(probative value outweighed by prejudice, confusing, waste of time), FRE 602
`
`(lack of personal knowledge), FRE 701 (opinion by lay witness), and FRE 702/703
`
`(insufficient support for expert testimony). In addition, Medtronic objects to
`
`Exhibit 2124 under FRE 802 (hearsay) to the extent that Medtronic does not have
`
`the opportunity to cross-examine Mr. Keith regarding his declaration.
`
`II. Exhibits 2085, 2086: Ressemann Deposition Exhibits
`
`Medtronic objects under FRE 106 (completeness), FRE 401/402 (relevance),
`
`FRE 403 (probative value outweighed by prejudice, confusing, waste of time), and
`
`FRE 802 (hearsay).
`
`
`
`1
`
`
`
`IPR2020-00127
`Patent 8,048,032
`
`III. Exhibit 2116: Deposition Transcript of Stephen J.D. Brecker, M.D.
`
`
`
`Medtronic objects to Exhibit 2116 under FRE 401/402 (relevance) and FRE
`
`403 (probative value outweighed by prejudice, confusing, waste of time).
`
`Medtronic reasserts and reserves all of its objections under 37 C.F.R. § 42.64(a)
`
`made during the August 11, 2020 and September 14, 2020 depositions of Stephen
`
`J.D. Brecker, M.D.
`
`IV. Exhibit 2137: Deposition Transcript of Richard A. Hillstead, Ph.D.
`
`Medtronic objects to Exhibit 2137 under FRE 401/402 (relevance) and FRE
`
`403 (probative value outweighed by prejudice, confusing, waste of time).
`
`Medtronic reasserts and reserves all of its objections under 37 C.F.R. § 42.64(a)
`
`made during the September 11, 2020 and September 15, 2020 depositions of
`
`Richard A. Hillstead, Ph.D.
`
`Dated: October 1, 2020
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`
`
`/Cyrus A. Morton/
`Cyrus A. Morton
`Reg. No. 44,954
`Robins Kaplan LLP
`2800 LaSalle Plaza
`800 LaSalle Avenue
`Minneapolis, MN 55402
`Attorney for Petitioner
`
`
`
`2
`
`
`
`IPR2020-00127
`Patent 8,048,032 B2
`
`
`CERTIFICATE OF SERVICE
`Pursuant to 37 C.F.R. § 42.6(e)(4), the undersigned certifies that on October
`
`1, 2020, a copy of PETITIONERS’ OBJECTIONS UNDER 37 C.F.R. § 42.64 TO
`
`PATENT OWNER’S POST-INSTITUTION EVIDENCE was served in its entirety
`
`by electronic mail on Patent Owner’s counsel at the following addresses indicated
`
`in Patent Owner’s Mandatory Notices:
`
`J. Derek Vandenburgh, Reg. No. 32,179
`dvandenburgh@carlsoncaspers.com
`
`Dennis C. Bremer, Reg. No. 40,528
`dbremer@carlsoncaspers.com
`
`Joseph W. Winkels
`jwinkels@carlsoncaspers.com
`
`Peter M. Kohlhepp
`pkohlhepp@carlsoncaspers.com
`
`
`
`Dated: October 1, 2020
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`
`
`/Cyrus A. Morton/
`Cyrus A. Morton
`Reg. No. 44,954
`Robins Kaplan LLP
`2800 LaSalle Plaza
`800 LaSalle Avenue
`Minneapolis, MN 55402
`Attorney for Petitioner
`
`3
`
`